Ross is a Director and CEO of all Bruce Mathieson Group private family companies, Director of ALH Group Pty Ltd, since 2004 and Chief Operating Officer 2004 – 2014. He is also a Director of Beovista Pty Ltd, an energy saving machine manufacturer and operator, and Director of GreyScan Pty Ltd, world’s first inorganic explosive detector, and Firefly Health Pty Ltd, non-invasive personal hypoglycaemic monitoring for Type 1 diabetics.
Ross has a Bachelor of Commerce from the University of Melbourne and is Fellow, Certified Practising Accountants (FCPA).
Mario Gattino – CEO, Director
Mr Gattino is an internationally networked and award winning senior executive with 25+ years’ experience in pivotal ‘C’ suite leadership roles, realigning underperforming enterprises with comprehensive change leadership, crisis management and organisational turnaround expertise.
His experience is highly influenced by a distinguished 20 year career at Pfizer Inc. contributing to a long successful track record in commercialising drug and device products globally and growing sales in multiple markets including the USA, Europe and Asia. Taking on business critical international roles in complex commercial and sociopolitical environments, executing sophisticated corporate refocus, high-performance teambuilding and extensive stakeholder liaison of all major regulatory agencies (FDA,EMEA, TGA etc…) to deliver resounding profitability and viability.
Mr Gattino is a specialist in executive leadership and crisis management supported by high-caliber strategic planning and operational execution in complex project management, brand commercialisation, global portfolio execution, business development via M&A and licensing plus sophisticated stakeholder management.
Qualifications: MBA (Distinction) and Graduate Diploma in Management, University of New South Wales (Australian Graduate School of Management), Bachelor’s Degree Applied Science (Medical Administration) La Trobe University, Graduate (GAICD) Australian Institute of Company Directors, Executive Leadership Program, Harvard Business School.
Professor Bruce Thompson B.app.Sci, CRFS, FANZSRS, FThorSoc, FAPSR, PhD
Bruce is Head, Physiological Services at The Alfred Hospital, one of the largest lung function laboratories in Australia, Adjunct Professor, Central Clinical School, Monash University and will take up his new role as Dean, School of Health Sciences at Swinburne University of Technology in 2019.
He is the President-elect of the Thoracic Society of Australia and New Zealand and is a member of a number of other professional associations including the Asia Pacific Society of Respirology, American Thoracic Society, European Respiratory Society, National Health and Medical Research Council, Institute for Breathing and Sleep, Lung Health Promotion Centre, National Science Week and World Congress in Biomedical Engineering. Bruce has been the recipient of over $34 million in competitive grants for research, has contributed to Government Policy Documents and is the author of numerous peer reviewed journal articles and official documents. Bruce is also Chair of Respiri’s Australian Medical and Scientific Advisory Board.